Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» reverse merger
reverse merger
Conditions are ripe for reverse mergers
Conditions are ripe for reverse mergers
EP Vantage
M&A
reverse merger
Redx
Jounce Therapeutics
Pherecydes
Erytech
Flame Biosciences
Leap Therapeutics
Elicio Therapeutics
Angion
Flag link:
Bone Fixes Fracture with "Synergistic" Reverse Merger, Becomes BioSenic
Bone Fixes Fracture with "Synergistic" Reverse Merger, Becomes BioSenic
BioSpace
Bone Therapeutics
cell therapy
M&A
reverse merger
Medsenic
BioSenic
Flag link:
As Forte fails, who might yet improve the image of reverse mergers?
As Forte fails, who might yet improve the image of reverse mergers?
EP Vantage
reverse merger
M&A
Forte Biosciences
Tocagen
Flag link:
Nautilus set to go public in reverse merger with Perceptive SPAC, aims to test proteomics platform with big-name backers
Nautilus set to go public in reverse merger with Perceptive SPAC, aims to test proteomics platform with big-name backers
Endpoints
Nautilus Biotechnology
NASDAQ
SPAC
IPOs
reverse merger
M&A
Arya Sciences
Flag link:
Obliterated by Alzheimer's failure, Neurotrope relinquishes its Nasdaq spot in reverse merger
Obliterated by Alzheimer's failure, Neurotrope relinquishes its Nasdaq spot in reverse merger
Endpoints
M&A
reverse merger
Neurotrope BioSciences
Metuchen
Petros
Flag link:
Reverse mergers give and they take away
Reverse mergers give and they take away
EP Vantage
Conatus
NewLink
reverse merger
M&A
Histogen
Lumos Pharma
Flag link:
In the latest reverse merger, Vienna's Arsanis serves as vehicle for X4 Pharma's Nasdaq listing
In the latest reverse merger, Vienna's Arsanis serves as vehicle for X4 Pharma's Nasdaq listing
Endpoints
biotech
reverse merger
M&A
Arsanis
X4 Pharma
Flag link:
Acer aims for public listing through reverse merger
Acer aims for public listing through reverse merger
BioPharma Dive
Acer
reverse merger
M&A
Opexa Therapeutics
Flag link:
Former Dendreon CEO debuts new public company in reverse merger
Former Dendreon CEO debuts new public company in reverse merger
BioPharma Dive
Dendreon
reverse merger
Mitchell Gold
Alpine Immune Sciences
Nivalis
Flag link: